baseline for both groups overlapped for both sides of the face, confirming a comparable treatment effect. Responder rates based on WAS were slightly higher for the reference group than the treatment group at earlier time points in the study, however this difference decreased over time and values were similar between the groups at week 48 (Figure 1). The mean change from baseline in WAS score at week 48 for FST I–III, FST IV, and FST V–VI subjects within the treatment group was similar for both sides of the face. Representative subject photographs are presented in Figures 2–3.
